Classification of acute leukemias according to the First Latinamerican Consensus Conference for the immunophenotyping of leukemia;Clasificación de las leucemias agudas de acuerdo con el consenso de la primera conferencia latinoamericana en la tipificación inmunológica de las leucemias

Revista de Investigacion Clinica

Volumn 52, Issue 5, 2000, Pages 524-528

  Piedras, Josefa ^a   Barrales Benítez, Olga ^a   López Karpovitch, Xavier ^a  

^a INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

Author keywords

Acute leukemia; Immunophenotyping; Latinamerican consensus

Indexed keywords

ACUTE DISEASE; ARTICLE; CLASSIFICATION; CONSENSUS DEVELOPMENT; HUMAN; IMMUNOLOGY; IMMUNOPHENOTYPING; LEUKEMIA; SOUTH AND CENTRAL AMERICA;

ACUTE DISEASE; CONSENSUS DEVELOPMENT CONFERENCES; HUMANS; IMMUNOPHENOTYPING; LATIN AMERICA; LEUKEMIA;

EID: 0347608783     PISSN: 00348376     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Lanza F. European Working Group on Leukemia Immunophenotyping. Toward standardization in immunophenotyping hematological malignancies. How can we improve the reproducibility and comparability of flow cytometric results? Eur J Histochem 1996; 40(suppl. 1): 7-14.
2. Rothe G, Schmitz G. Working Group on Flow Cytometry and Image Analysis. Consensus protocol for the flow cytometric immunophenotyping of hematopoietic malignancies. Leukemia 1996; 10: 877-95.
3. Ruiz-Argüelles A, Duque RE, Orfao A. Primera conferencia latinoamericana de consenso en la tipificación inmunológica de leucemias. Rev Invest Clin 1997; 49:317-22.
4. Van Noesel CJM, van Lier RAW, Cordell JL, Tse AGD, van Schijndel GMW, de Vries EFR et al. The membrane IgM-associated heterodimer on human B cells is a newly defined B cell antigen that contains the protein product of the mb-1 gene. J Immunol 1991; 146:3881-8.
5. Mason DY, Cordell JL, Tse AGD, van Dongen JJM, van Noesel CJM, Micklem K et al. The IgM-associated protein mb-1 as a marker of normal and neoplastic B cells. J Immunol 1991; 147: 2474-82.
6. Buccheri V, Mihaljevic B, Matutes E, Dyer MJS, Mason DY, Catovsky D. Mb-1: a new marker for B-lineage lymphoblastic leukemia. Blood 1993; 82: 853-7.
7. Van Dongen JJM, Krissansen GW, Wolvers-Tettero ILM, ComansBitter WM, Adriaansen HJ, Hooijkaas H et al. Cytoplasmic expression of the CD3 antigen as a diagnostic marker for immature T-cell malignancies. Blood 1988; 71: 603-12.
8. Nguyen PL, Olszak I, Harris NL, Preffer FI. Myeloperoxidase detection by three-color flow cytometry and by enzyme cytochemistry in the classification of acute leukemia. Am J Clin Pathol 1998; 110: 163-9.
9. Piedras J, López-Karpovitch X, Cárdenas MR. Inmunofenotipos celulares en 97 adultos con leucemia aguda. Rev Invest Clin 1997; 49: 457-64.
10. San-Miguel JF, Duque RE. Utilidad del inmunofenotipo en el diagnóstico y clasificación de las leucemias agudas. En Ruiz-Argüelles GJ, San Miguel JF, eds. Actualización en leucemias. México: Panamericana; 1966: 25-34.
11. Nadler LM, Korsmeyer SJ, Anderson KC, Boy AW, Slaughenhoupt B, Park E et al. B cell origin of non-T cell acute lymphoblastic leukemia. A model for discrete stages of neoplastic and normal pre-B cell differentiation. J Clin Invest 1984; 74: 332-40.
12. Cortes JE, Kantarjian HM. Acute lymphoblastic leukemia. A comprehensive review with emphasis on biology and therapy. Cancer 1995; 76: 2393-417.
13. Sullivan MP, Pullen DJ, Crist WM, Brecher M, Ramirez I, Sabio H et al. Clinical and biological heterogeneity of childhood B cell lymphocytic leukemia: implications for clinical trials. Leukemia 1990; 4: 6-11.
14. Fenaux P, Lai JL, Miaux O, Zandecki M, Jouet JP, Bauters F. Burkitt cell acute leukaemia (L3 ALL) in adults: a report of 18 cases. Br J Haematol 1989; 71: 371-6.
15. Crist WM, Grossi CE, Pullen DJ, Cooper MD. Immunologic markers in childhood acute lymphocytic leukemia. Semin Oncol 1985; 12: 105-21.
16. Koehler M, Behm FG, Shuster J, Crist W, Borowitz M, Look AT et al. Transitional pre-B-cell acute lymphoblastic leukemia of childhood is associated with favorable prognostic clinical features and an excellent outcome: A Pediatric Oncology Group Study. Leukemia 1993; 7: 2964-8.
17. López-Karpovitch X, Piedras J. Transitional pre-B-cell acute lymphoblastic leukemia in adults. Am J Hematol 1999; 61: 274-5.
18. Kita K, Miwa H, Nakase K, Kawakami K, Kobayashi T, Shirakawa S et al. Clinical importance of CD7 expression in acute myelocytic leukemia. Blood 1993; 81: 2399-405.
19. Khalidi HS, Medeiros LJ, Chang KL, Brynes RK, Slovak ML, Arber DA. The immunophenotype of adult acute myeloid leukemia: high frequency of lymphoid antigen expression and comparison of immunophenotype, French-American-British classification, and karyotypic abnormalities. Am J Clin Pathol 1998; 109: 211-20.
20. Traweek ST. Immunophenotypic analysis of acute leukemia. Am J Clin Pathol 1993; 99: 504-12.
21. Drach D, Drach J, Glassl H, Gattringer C, Huber H. Flow cytometric detection of cytoplasmic antigens in acute leukemias: implications for lineage assignment. Leuk Res 1993; 17: 455-61.
22. Farahat N, van der Plas D, Praxedes M, Morilla E, Catovsky D. Demonstration of cytoplasmic and nuclear antigens in acute leukaemia using flow cytometry. J Clin Pathol 1994; 47: 843-9.
23. Pui C-H, Hancock ML, Head DR, Rivera GJ, Look T, Sandlund JT et al. Clinical significance of CD34 expression in childhood acute lymphoblastic leukemia. Blood 1993; 82: 889-94.
24. Czuczman MS, Dodge RK, Stewart CC, Frankel SR, Davey FR, Powell BL et al. Value of immunophenotype in intensively treated adult acute lymphoblastic leukemia: cancer and leukemia Group B Study 8364. Blood 1999; 93:3931-9.